Search results for "Symptomatic"

showing 10 items of 479 documents

Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency.

2012

SummaryIndividuals with inherited factor VII (FVII) deficiency display bleeding phenotypes ranging from mild to severe, with 30% of patients having always been asymptomatic (non-bleeding). In 626 FVII-deficient individuals, by analysing data from the International Factor VII (IF7) Registry and the Seven Treatment Evaluation Registry (STER), we determined whether bleeding type at disease presentation and FVII coagulant activity (FVIIc) predict ensuing bleeds. At disease presentation/diagnosis, 272 (43.5%) individuals were non-bleeding, 277 (44.2%) had minor bleeds, and 77 (12.3%) had major bleeds. During a median nine-year index period (IP) observation, 87.9% of non-bleeding individuals at p…

RegistrieMalePediatricsFactor VII DeficiencyInternational CooperationAsymptomatic individual030204 cardiovascular system & hematologychemistry.chemical_compound0302 clinical medicineRetrospective StudieAge FactorRegistriesYoung adultChildClinical Trials as TopicHematologyFactor VIIAge FactorsHematologyFactor VIIMiddle AgedPhenotypeTreatment OutcomeChild PreschoolFemalePresentation (obstetrics)medicine.symptomHumanAdultQuality ControlRiskmedicine.medical_specialtyAdolescentHemorrhageAsymptomaticMajor bleed03 medical and health sciencesYoung AdultInternal medicinemedicineHumansRetrospective StudiesModels Statisticalbusiness.industryMinor bleedInfantRetrospective cohort studychemistryDisease PresentationRelative riskbusiness030215 immunologyThrombosis and haemostasis
researchProduct

Severity of Asymptomatic Carotid Stenosis and Risk of Ipsilateral Hemispheric Ischaemic Events: Results from the ACSRS Study

2005

Objectives. This study determines the risk of ipsilateral ischaemic neurological events in relation to the degree of asymptomatic carotid stenosis and other risk factors. Methods. Patients (n = 1115) with asymptomatic internal carotid artery (ICA) stenosis greater than 50% in relation to the bulb diameter were followed up for a period of 6-84 (mean 37.1) months. Stenosis was graded using duplex, and clinical and biochemical risk factors were recorded. Results. The relationship between ICA stenosis and event rate is linear when stenosis is expressed by the ECST method, but S-shaped if expressed by the NASCET method. In addition to the ECST grade of stenosis (RR 1.6; 95% CI 1.21-2.15), histor…

Riskmedicine.medical_specialtymedicine.medical_treatmentCarotid StenosiPredictive Value of TestCarotid endarterectomySeverity of Illness IndexAsymptomaticBrain Ischemiachemistry.chemical_compoundCerebrovascular Accidentmedicine.arteryInternal medicineSeverity of illnessNASCETMED/22 - CHIRURGIA VASCOLAREmedicineCarotidStenosisMedicine(all)Ultrasonography Doppler DuplexCreatininebusiness.industryRisk FactorIncidence (epidemiology)medicine.diseasemajor clinical studyUltrasonography Duplex DopplerAsymptomaticStenosischemistryPredictive value of testsCardiologySurgeryECSTRadiologyInternal carotid arterymedicine.symptomCardiology and Cardiovascular MedicinebusinessHumanEuropean Journal of Vascular and Endovascular Surgery
researchProduct

SARS-CoV-2 Antibody Screening in Healthcare Workers in Non-Infectious Hospitals in Two Different Regions of Southern Poland (Upper Silesia and Opole …

2021

(1) Background: Detection of asymptomatic or subclinical human coronavirus SARS-CoV-2 infection in healthcare workers (HCWs) is crucial for understanding the overall prevalence of the new coronavirus and its infection potential in public (non-infectious) healthcare units with emergency wards. (2) Methods: We evaluated the host serologic responses, measured with semi-quantitative ELISA tests (IgA, IgG, IgM abs) in sera of 90 individuals in Hospital no. 4 in Bytom, 84 HCWs in the University Hospital in Opole and 25 in a Miasteczko Śląskie local surgery. All volunteers had negative RT-PCR test results or had not had the RT-PCR test performed within 30 days before sampling. The ELISA test was m…

SARS-CoV-2; COVID-19; RT-PCR; asymptomatic; health-care professionals; serological surveillance; antibody screening; immunoglobulinsmedicine.medical_specialtyHealth PersonnelHealth Toxicology and MutagenesisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)serological surveillanceimmunoglobulinsRT-PCRAsymptomaticArticleantibody screeningSerology03 medical and health sciences0302 clinical medicineInternal medicineHealth caremedicineHumansasymptomaticProspective Studies030212 general & internal medicineProspective cohort study030304 developmental biologySubclinical infection0303 health scienceshealth-care professionalsbusiness.industrySARS-CoV-2Public Health Environmental and Occupational HealthRCOVID-19virus diseasesMedicinePolandmedicine.symptombusinessNon infectiousAntibody screeningInternational Journal of Environmental Research and Public Health; Volume 18; Issue 8; Pages: 4376
researchProduct

2020

Abstract A person-centered approach was used to identify the profiles of symptoms of psychological ill-being among Finnish upper secondary education students (N = 2889); to examine whether gender and educational track (i.e., academic or vocational) are associated with these profiles; and to investigate the role of profiles in school dropout intentions. Using latent profile analysis, one asymptomatic profile (normative, 79.2%) and three symptomatic profiles (internalizing symptoms, 9.1%; externalizing symptoms, 9.1%; and comorbid symptoms, 2.6%) were identified. Boys in the vocational track were overrepresented in the externalizing-symptoms profile, whereas girls in both tracks were overrepr…

Secondary levelSocial Psychology4. Educationeducation05 social sciences050301 educationOut of schoolAsymptomaticPerson-centered therapyEducationSchool dropoutVocational educationDevelopmental and Educational PsychologymedicineNormative0501 psychology and cognitive sciencesmedicine.symptomPsychology0503 educationDropout (neural networks)050104 developmental & child psychologyClinical psychologyLearning & Individual Differences
researchProduct

Screening for Early Detection of Asymptomatic Coronary Artery Disease (Secondary Prevention): An Approach to Cost/Benefit and Cost/Effectiveness Anal…

1983

Classification of different types of preventive measures for ischemic heart disease (IHD) has been much debated. In the classical use of terms “primary prevention” (prevention of occurrence) includes removal of risk factors in otherwise healthy individuals, while the attempts to change diet and life style in the very early age, in order to avoid the acquisition of risk factors, has been called “preprimary prevention” or “early prevention.”

Secondary preventionmedicine.medical_specialtybusiness.industryEarly detectionCost-effectiveness analysisDiseasemedicine.diseaseAsymptomaticCoronary artery diseaseInternal medicinemedicineCardiologyCost benefitmedicine.symptomIntensive care medicineIschemic heartbusiness
researchProduct

Streptococcus agalactiae and Chlamydia trachomatis detection in women without symptoms of infection.

2020

Background Chlamydia trachomatis (C. trachomatis) and Streptococcus agalactiae (GBS) may be present in the female cervical canal without any symptoms of infection. Chronic chlamydial infections lead to many serious complications and perinatal infections, while the presence of GBS is a reservoir for infections of newborns or invasive streptococcal infection in adults. Objectives To examine healthy women for C. trachomatis without symptoms from the reproductive system, assess the frequency of asymptomatic infections, detect GBS in the cervical canal, demonstrate differences in drug susceptibility, and determine the serotype of S. agalactiae strains and correlations among the ones present in t…

SerotypeAdultcervical infectionMedicine (miscellaneous)ErythromycinChlamydia trachomatisMicrobial Sensitivity Testsmedicine.disease_causeAsymptomaticGeneral Biochemistry Genetics and Molecular BiologySerologyMicrobiologyStreptococcus agalactiaePregnancyStreptococcal InfectionsDrug Resistance BacterialInternal MedicinemedicineHumansPharmacology (medical)Genetics (clinical)business.industryInfant NewbornClindamycinChlamydia InfectionsAnti-Bacterial AgentsPenicillinStreptococcus agalactiaeReviews and References (medical)FemalePolandmedicine.symptombusinessChlamydia trachomatismedicine.drugAdvances in clinical and experimental medicine : official organ Wroclaw Medical University
researchProduct

Parental Stress and Parental Ratings of Behavioral Problems of Enuretic Children.

2019

Background: Primary monosymptomatic nocturnal enuresis (PMNE) may have a stressful impact on the everyday life of children and parents, and it may represent a cumulative stress factor increasing feelings of "learned helplessness." Methods: The current study investigated parental stress in a group of parents (n = 330) of children affected by PMNE, compared to a group of parents (n = 330) of typical developing children (TDC). In addition, the study evaluated whether parents of PMNE children experience more emotional, social, and behavioral problems in their children, compared to parents of TDC. Finally, the study correlated frequency of enuresis with stress values and Child Behavior Checklist…

Settore M-PSI/01 - Psicologia GeneraleStress managementmedia_common.quotation_subjectprimary monosymptomatic nocturnal enuresis (PMNE) parental stress CBCL (child behavior checklist) parenting stress index-short form self-rating scalesCBCLLearned helplessnessparenting stress index-short formparental stresslcsh:RC346-42903 medical and health sciencesprimary monosymptomatic nocturnal enuresis (PMNE)0302 clinical medicineEnuresisStress (linguistics)medicine030212 general & internal medicineEveryday lifeChild Behavior Checklistself-rating scaleslcsh:Neurology. Diseases of the nervous systemmedia_commonOriginal ResearchCBCL (child behavior checklist)Settore M-PSI/02 - Psicobiologia E Psicologia FisiologicaSettore MED/39 - Neuropsichiatria InfantileFeelingNeurologyNeurology (clinical)medicine.symptomPsychology030217 neurology & neurosurgeryClinical psychologyFrontiers in neurology
researchProduct

The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial.

2014

BackgroundTiotropium, a once-daily long-acting anticholinergic bronchodilator, has demonstrated efficacy in patients with asthma who were symptomatic despite treatment with medium- to high-dose inhaled corticosteroids (ICS).ObjectiveThe objective of this study was to evaluate the efficacy and safety of once-daily tiotropium Respimat (5 μg or 2.5 μg), compared with placebo Respimat, as add-on therapy to low- to medium-dose ICS for adults with symptomatic asthma.MethodsA phase III, double-blind, placebo-controlled trial was conducted (NCT01316380). Adults with symptomatic asthma receiving low- to medium-dose ICS (200-400 μg budesonide or equivalent dose) and a pre-bronchodilator forced expira…

SpirometryBudesonideAdultMaleRespimatmedicine.drug_classSymptomaticAnticholinergicMildPlacebo03 medical and health sciences0302 clinical medicineBronchodilatorsAdrenal Cortex HormonesBronchodilatorControlAdministration InhalationImmunology and AllergyMedicineHumans030212 general & internal medicineTiotropium BromideBudesonideAnticholinergic; Asthma; Bronchodilators; Control; GINA; ICS; Mild; Respimat; Symptomatic; Tiotropium; Administration Inhalation; Adrenal Cortex Hormones; Adult; Asthma; Bronchodilator Agents; Budesonide; Disease Progression; Drug Combinations; Female; Humans; Male; Placebo Effect; Spirometry; Tiotropium Bromide; Treatment Outcome; Immunology and AllergyAsthmamedicine.diagnostic_testbusiness.industryTiotropiumTiotropium bromidemedicine.diseasePlacebo EffectGINAAsthmarespiratory tract diseasesRespimatBronchodilator AgentsDrug CombinationsTreatment OutcomeInhalation030228 respiratory systemTolerabilityICSSpirometryAnesthesiaAdministrationDisease ProgressionFemalebusinessmedicine.drugThe journal of allergy and clinical immunology. In practice
researchProduct

Marginal hazard ratio estimates in joint frailty models for heart failure trials

2019

Abstract This work is motivated by clinical trials in chronic heart failure disease, where treatment has effects both on morbidity (assessed as recurrent non‐fatal hospitalisations) and on mortality (assessed as cardiovascular death, CV death). Recently, a joint frailty proportional hazards model has been proposed for these kind of efficacy outcomes to account for a potential association between the risk rates for hospital admissions and CV death. However, more often clinical trial results are presented by treatment effect estimates that have been derived from marginal proportional hazards models, that is, a Cox model for mortality and an Andersen–Gill model for recurrent hospitalisations. …

Statistics and ProbabilityBiometryleast false parameterDiseasejoint frailty modelRisk AssessmentStudy durationCardiovascular deathunexplained heterogeneitymedicineHumansTreatment effectComplex Regression ModelsProportional Hazards ModelsHeart FailureClinical Trials as TopicProportional hazards modelbusiness.industryheart failure trialsHazard ratioGeneral Medicinemedicine.diseaseClinical trialrecurrent eventsHeart failureAsymptomatic DiseasesStatistics Probability and UncertaintybusinessDemographyResearch PaperBiometrical Journal. Biometrische Zeitschrift
researchProduct

THERAPEUTIC EFFICACY OF MAGNESIUM VALPROATE IN SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY

2012

Succinic semialdehyde dehydrogenase deficiency (SSADHD or gammahydroxybutyric aciduria), a disorder of γ-aminobutyric acid (GABA) metabolism, manifests as a slowly progressive or static encephalopathy. The latter encompasses prominent cognitive dysfunction, neuropsychiatric morbidity and epilepsy.We report safe and effective treatment with MgVPA in an adolescent female with SSADHD and seizures refractory to a broad spectrum of antiepileptics. MgVPA therapy (20 mg/Kg/day) was introduced at 7 years based upon behavioural difficulties and EEG alterations without adverse effects. Therapy was halted at age 13 years, and reintroduced at 14 years, due to new onset complex partial seizures. EEG dem…

Succinic semialdehyde dehydrogenase deficiencySSADHDbusiness.industrySymptomatic seizuresTHERAPEUTIC EFFICACY OF MAGNESIUM VALPROATE IN SUCCINIC SEMIALDEHYDE DEHYDROGENASEStatus epilepticusPharmacologymedicine.diseaseSettore MED/39 - Neuropsichiatria InfantileArticleBroad spectrumEpilepsyNeurodevelopmental disorderConcomitantMAGNESIUM VALPROATEmedicinemedicine.symptomGABAMgVPAbusinessMagnesium Valproate
researchProduct